Passive immunotherapy in neonatal calves--I. Safety and potency of a J5 Escherichia coli hyperimmune plasma in neonatal calves

By Selim S.A.   Cullor J.S.   Oelsner I.E.  

Vaccine, Vol. 13, Iss. 15, 1995-01 ,pp. : 1449-1453

Elsevier

Access to resources Recommend Favorite

The effect of Escherichia coli J5 and modified live Salmonella dublin vaccines in artificially reared neonatal calves

By Selim S.A.   Cullor J.S.   Smith B.P.   Blanchard P.   Farver T.B.   Hoffman R.   Dilling G.   Da Roden L.   Wilgenburg B.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 381-390

Elsevier

Access to resources Recommend Favorite

Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves

By Lemaire M.   Hanon E.   Schynts F.   Meyer G.   Thiry E.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1013-1017

Elsevier

Access to resources Recommend Favorite

The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves

By West K.   Petrie L.   Konoby C.   Haines D.M.   Cortese V.   Ellis J.A.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 907-919

Elsevier

Access to resources Recommend Favorite

Sublingual immunotherapy of allergic diseases

By Werner-Klein Melanie   Kalkbrenner Frank   Erb Klaus J  

Expert Opinion on Drug Delivery, Vol. 3, Iss. 5, 2006-09 ,pp. : 599-612

Informa Healthcare

Access to resources Recommend Favorite